MARKET

SLXNW

SLXNW

Silexion Therapeutics Corp
NASDAQ
0.0127
+0.0002
+1.60%
Closed 15:10 08/14 EDT
OPEN
0.0179
PREV CLOSE
0.0125
HIGH
0.0196
LOW
0.0127
VOLUME
37.19K
TURNOVER
--
52 WEEK HIGH
0.1508
52 WEEK LOW
0.0104
MARKET CAP
--
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
1D
Silexion Therapeutics GAAP EPS of -$5.17
Seeking Alpha · 1d ago
Press Release: Silexion Therapeutics Reports -2-
Dow Jones · 2d ago
Silexion Therapeutics Executes Reverse Share Split Amid Strain
TipRanks · 2d ago
Silexion Therapeutics Closes Public Offering and Strengthens Equity
TipRanks · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 3d ago
Nasdaq Surges 150 Points; US Inflation Rate Slows To 3.4% In July
Benzinga · 3d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 4d ago
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Benzinga · 4d ago
More
About SLXNW
Silexion Therapeutics Corp is an Israel-based oncology-focused biotechnology company. The Company is engaged in development of treatments for unsatisfactorily treated solid tumor cancers, which have the mutated KRAS oncogene. The KRAS gene is an oncogene that is involved in regulation of cell division as a result of its ability to relay external signals to the cell nucleus. Based on its research of refractory solid tumor cancers, it is developing a platform focused on the silencing of the KRAS oncogene using ribonucleic acid (RNA)-interference therapeutics. Its lead product candidate, SIL-204B, consists of locally administered small interfering RNAs (siRNA), in an extended-release formulation, as a preferred treatment of locally advanced pancreatic cancer patients, in combination with standard-of-care chemotherapy. Its clinical-stage pipeline is focused on treatment for pancreatic cancer (PC) tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected.

Webull offers Silexion Therapeutics Corp stock information, including NASDAQ: SLXNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLXNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLXNW stock methods without spending real money on the virtual paper trading platform.